|
|
|
|
Vol. 58, Issue 4, 756-762, October 2000
-Aminobutyric Acid Type A Receptors
Department of Pharmacology (M.D., J.G.N., J.M.C.D., S.M.J.D.) and
Division of Neuroscience (S.M.J.D.), Faculty of Medicine, University of
Alberta, Edmonton, Alberta, Canada; and Pharmaceutical and Biological
Sciences, Aston University, Aston Triangle, Birmingham, United Kingdom
(I.L.M.)
Zopiclone is a cyclopyrrolone that is used clinically as a hypnotic.
Although this drug is known to interact with neuronal
-aminobutyric
acid type A receptors, its binding site(s) within the receptor
oligomer has been reported to be distinct from that of the classical
benzodiazepines. After photoaffinity labeling with flunitrazepam,
receptors in rat cerebellar membranes showed differentially reduced
affinity for flunitrazepam and zopiclone by 50- and 3-fold,
respectively. Because histidine 101 of the
-subunit is a major site
of photolabeling, we have made specific substitutions of this residue
and studied the consequences on the binding properties of zopiclone and
diazepam using recombinant
1
2
2-receptors transiently expressed
in tsA201 cells. Both compounds showed similar binding profiles with
receptors containing mutated
-subunits, suggesting a similar
interaction with the residue at position 101. At
1
2
3-receptors, flunitrazepam affinity was dramatically
decreased by approximately 36-fold, whereas the affinity for zopiclone
was decreased only 3-fold, suggesting a differential contribution of
the
-subunit to the binding pocket. Additionally, we used
electrophysiological techniques to examine the contribution of the
-subunit isoform in the receptor oligomer to ligand recognition using recombinant receptors expressed in Xenopus
oocytes. Both compounds are agonists at
1
2
2- and
1
2
3-receptors, with flunitrazepam being more potent but less
efficacious. In summary, these data suggest that histidine 101 of the
1-subunit plays a similar role in ligand recognition for zopiclone,
diazepam, and flunitrazepam.
This article has been cited by other articles:
![]() |
M. W. Fleck Molecular Actions of (S)-Desmethylzopiclone (SEP-174559), an Anxiolytic Metabolite of Zopiclone J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 612 - 618. [Abstract] [Full Text] [PDF] |
||||